Loading...
Designing and Development of a Tandem Bivalent Nanobody against VEGF(165)
BACKGROUND: Inhibition of angiogenesis using monoclonal antibodies is an effective strategy in cancer therapy. However, they could not penetrate sufficiently into solid tumors. Antibody fragments have solved this issue. However, they suffer from short in vivo half-life. In the current study, a tande...
Na minha lista:
| Udgivet i: | Avicenna J Med Biotechnol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Avicenna Research Institute
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8112138/ https://ncbi.nlm.nih.gov/pubmed/34012520 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18502/ajmb.v13i2.5519 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|